Moreover, genetic evidence obtained in mice models for ALS indicate that lack of expression of mutant SOD1 in GFAP expressing astrocytes [7], but not astrocyte ablation [31], sharply slowed disease progression. Here, GFAP is linked to amyotrophic lateral sclerosis.